ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 138 filers reported holding ARRAY BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $10,216,000 | -29.6% | 1,142,744 | -30.7% | 0.39% | -34.0% |
| Q4 2016 | $14,504,000 | +30.2% | 1,650,000 | 0.0% | 0.60% | +15.3% |
| Q3 2016 | $11,138,000 | -62.6% | 1,650,000 | -80.3% | 0.52% | -55.7% |
| Q2 2016 | $29,765,000 | +5.9% | 8,361,069 | -12.3% | 1.17% | -2.3% |
| Q1 2016 | $28,112,000 | -23.7% | 9,529,361 | +9.2% | 1.20% | -19.8% |
| Q4 2015 | $36,838,000 | -17.0% | 8,729,361 | -10.3% | 1.49% | -13.0% |
| Q3 2015 | $44,366,000 | -35.4% | 9,729,361 | +2.1% | 1.72% | -25.0% |
| Q2 2015 | $68,707,000 | -21.2% | 9,529,361 | -19.5% | 2.29% | -19.0% |
| Q1 2015 | $87,221,000 | +55.8% | 11,834,595 | 0.0% | 2.82% | +40.5% |
| Q4 2014 | $55,978,000 | +28.5% | 11,834,595 | -3.0% | 2.01% | +26.6% |
| Q3 2014 | $43,574,000 | -21.7% | 12,205,673 | 0.0% | 1.59% | -29.0% |
| Q2 2014 | $55,658,000 | -3.0% | 12,205,673 | 0.0% | 2.24% | -4.4% |
| Q1 2014 | $57,367,000 | +1.9% | 12,205,673 | +8.6% | 2.34% | -19.7% |
| Q4 2013 | $56,289,000 | -14.5% | 11,235,406 | +6.1% | 2.92% | -4.8% |
| Q3 2013 | $65,841,000 | +33.2% | 10,585,406 | -2.8% | 3.06% | +31.5% |
| Q2 2013 | $49,420,000 | – | 10,885,406 | – | 2.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |